Dive Brief: Just days after the Food and Drug Administration issued its stance on approving complex generics more quickly, the agency did just that, giving the go-ahead to Mylan N.V.’s copycat version of the 40 mg/mL dose of Copaxone. Teva Pharmaceuticals Industries Ltd. has been staving off competition to its best-selling drug for years; first through legal...